NDC 0299-5980
Mirvaso
Brimonidine Tartrate
Mirvaso is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Galderma Laboratories, L.p.. The primary component is Brimonidine Tartrate.
| Product ID | 0299-5980_932a5eae-8406-4111-ac52-6ed7028d87da |
| NDC | 0299-5980 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mirvaso |
| Generic Name | Brimonidine Tartrate |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2013-08-23 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204708 |
| Labeler Name | Galderma Laboratories, L.P. |
| Substance Name | BRIMONIDINE TARTRATE |
| Active Ingredient Strength | 5 mg/g |
| Pharm Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 0299-5980-00
1 TUBE in 1 BLISTER PACK (0299-5980-00) > 2 g in 1 TUBE
| Marketing Start Date | 2013-08-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0299-5980-35 [00299598035]
Mirvaso GEL
| Marketing Category | NDA |
| Application Number | NDA204708 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2013-08-23 |
NDC 0299-5980-02 [00299598002]
Mirvaso GEL
| Marketing Category | NDA |
| Application Number | NDA204708 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-08-23 |
NDC 0299-5980-30 [00299598030]
Mirvaso GEL
| Marketing Category | NDA |
| Application Number | NDA204708 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2013-08-23 |
NDC 0299-5980-00 [00299598000]
Mirvaso GEL
| Marketing Category | NDA |
| Application Number | NDA204708 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-08-23 |
NDC 0299-5980-45 [00299598045]
Mirvaso GEL
| Marketing Category | NDA |
| Application Number | NDA204708 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-08-23 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| BRIMONIDINE TARTRATE | 5 mg/g |
OpenFDA Data
| SPL SET ID: | f6a4353f-ae69-4214-901f-e5d42a6fbde7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Adrenergic alpha-Agonists [MoA]
- alpha-Adrenergic Agonist [EPC]
- Adrenergic alpha-Agonists [MoA]
- alpha-Adrenergic Agonist [EPC]
NDC Crossover Matching brand name "Mirvaso" or generic name "Brimonidine Tartrate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0299-5980 | Mirvaso | brimonidine tartrate |
| 0023-9177 | ALPHAGAN P | brimonidine tartrate |
| 0023-9321 | ALPHAGAN P | brimonidine tartrate |
| 17478-715 | Brimonidine | Brimonidine Tartrate |
| 50090-1046 | Brimonidine | Brimonidine Tartrate |
| 14445-400 | Brimonidine Tartrate | Brimonidine Tartrate |
| 24208-411 | Brimonidine Tartrate | Brimonidine Tartrate |
| 25685-715 | Brimonidine Tartrate | brimonidine tartrate |
| 42843-501 | Brimonidine Tartrate | Brimonidine Tartrate |
| 50090-1800 | Brimonidine Tartrate | Brimonidine Tartrate |
| 50090-4224 | Brimonidine Tartrate | Brimonidine Tartrate |
| 60505-0564 | Brimonidine Tartrate | brimonidine tartrate |
| 61314-143 | Brimonidine Tartrate | Brimonidine Tartrate |
| 61314-144 | Brimonidine Tartrate | Brimonidine Tartrate |
| 63629-8792 | Brimonidine Tartrate | Brimonidine Tartrate |
| 24208-537 | LUMIFY Redness Reliever Eye Drops | BRIMONIDINE TARTRATE |
Trademark Results [Mirvaso]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MIRVASO 85455333 4437024 Live/Registered |
NESTLÃ SKIN HEALTH S.A. 2011-10-25 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.